Sort
30,917 grants matching “tumor microenvironment”
Development of a patient-derived organotypic spheroids (PDOTS) platform for prediction of clinical responses to immuno-oncology drugs
$381,800Amir Reza Aref · Xsphera Biosciences Incorporated · R43 · FY2021 · CA
Project 1: Overcoming Immune Exclusion in Microsatellite Stable Colorectal Cancer
$381,800Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2025 · CA
Genetics and Biology of Metastatic Colorectal Cancer
$381,760Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
PDK1 as a Novel Target in Melanoma
$381,728Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Projecdt 3 - Modulation of bone environment to enhance response of bone cancers
$381,718John F Dipersio · Washington University · U54 · FY2016 · CA
MicroRNA regulation of RasGAP's during angiogenesis
$381,687David A Cheresh · University Of California, San Diego · R01 · FY2015 · HL
Combination of hiPSCs and bioengineering to repair injured pediatric brain
$381,668Dong Sun · Virginia Commonwealth University · R01 · FY2017 · NS
Deciphering Mechanisms of Tumor-Stromal Interactions in Prostate Cancer
$381,656Boyang Wu · Washington State University · R01 · FY2022 · CA
Novel Nanotechnologies and Molecular Imaging Approaches for Cancer Immunotherapy
$381,654Caius Gabriel Radu · California Institute Of Technology · U54 · FY2010 · CA
Project 1 - Molecular Genetics of Human Papillomavirus Infection and Oncogenesis
$381,651Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2021 · CA
The role and mechanism of necrosis in glioblastoma
$381,650Wei Li · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2024 · NS
Augmenting T cell trafficking and functionality through novel combinations of epigenetic agents and PD-1 blockade
$381,646Amer Aziz Beg · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2019 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$381,617Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$381,617Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Imaging tumor associated macrophage (TAM) function
$381,606Ralph Weissleder · Massachusetts General Hospital · R01 · FY2017 · CA
Project 3: Localized microneedle-directed combination immunotherapy for cSCC
$381,600Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
$381,600Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Project 4: Neoadjuvant Clinical Trial with Pembrolizumab for Locally Advanaced Squamous Cell Carcinoma (SCC)
$381,600Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment
$381,589Jenny J Yang · Georgia State University · R33 · FY2021 · CA
Evolution and targeting of the functional states of glioblastoma
$381,554Anna Lasorella · University Of Miami School Of Medicine · R01 · FY2024 · CA
NAD+ Pathway Signaling in Glioblastoma Tumor Growth and Therapy Resistance
$381,536Albert Hong-Jae Kim · Washington University · R01 · FY2020 · NS
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
$381,507Shannon Celeste Kenney · University Of Wisconsin-Madison · R01 · FY2018 · CA
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
$381,507Shannon Celeste Kenney · University Of Wisconsin-Madison · R01 · FY2020 · CA
EBV LMP1/LMP2A Proteins Promote Hodgkin-like Lymphomas in Humanized Mice
$381,507Shannon Celeste Kenney · University Of Wisconsin-Madison · R01 · FY2021 · CA
Role of senescence in multiple myeloma tumorigenesis
$381,504Megan M Weivoda · Mayo Clinic Rochester · U01 · FY2025 · AG